Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000618659 | SCV000735595 | likely benign | Cardiovascular phenotype | 2016-11-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV000770116 | SCV000901542 | likely benign | Cardiomyopathy | 2016-07-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000867666 | SCV001008918 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV005404743 | SCV006067711 | likely benign | not specified | 2025-04-09 | criteria provided, single submitter | clinical testing | BP7 |
Prevention |
RCV004533271 | SCV004725015 | likely benign | TTN-related disorder | 2019-08-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |